We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Apyx Medical Corporation | NASDAQ:APYX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.06 | -4.26% | 1.35 | 1.35 | 1.39 | 1.50 | 1.30 | 1.41 | 35,769 | 23:56:50 |
|
|
|
|
|
|
CURRENT REPORT
|
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Date of Report (Date of earliest event reported)
|
August 1, 2019
|
|
APYX MEDICAL CORPORATION
|
(Exact name of registrant as specified in its charter)
|
Delaware
|
0-12183
|
11-2644611
|
(State or other jurisdiction of
incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer
Identification No.)
|
(Former name or former address, if changed since last report)
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
|
|
|
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock
|
APYX
|
Nasdaq Stock Market, LLC
|
|
|
|
|
|
|
(ii)
|
The Company’s stockholders ratified the appointment of BDO USA, LLC as its independent registered public accounting firm for the year ending December 31, 2019 by the following vote:
|
||
|
Votes For
|
Votes Against
|
Votes Abstained
|
|
24,866,812
|
90,331
|
10,941
|
|
|
|
|
|
|
(iii)
|
The Company’s stockholders approved the compensation of the named executive officers of the Company by the following vote:
|
||
|
Votes For
|
Votes Against
|
Votes Abstained
|
|
15,881,701
|
666,986
|
69,966
|
(iv)
|
The Company’s stockholders approved the frequency of an advisory vote on the compensation of the named executive officers of the Company by the following vote:
|
|||
|
1 Year
|
2 Years
|
3 Years
|
Votes Abstained
|
|
5,359,957
|
267,469
|
10,567,574
|
423,653
|
(v)
|
The Company’s stockholders approved the Company’s 2019 Share Incentive Plan by the following vote:
|
||
|
Votes For
|
Votes Against
|
Votes Abstained
|
|
13,501,094
|
3,035,918
|
81,641
|
Exhibit No.
|
Description
|
99.1
|
Date: August 7, 2019
|
|
APYX MEDICAL CORPORATION
|
|
|
|
|
|
|
By:
|
/s/ Tara Semb
|
|
|
|
Tara Semb
|
|
|
|
Chief Financial Officer and Secretary
|
|
1 Year Apyx Medical Chart |
1 Month Apyx Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions